Introduction

Knee osteoarthritis is a common joint condition that affects millions and can seriously impact quality of life. The gradual breakdown of cartilage leads to pain, stiffness, and difficulty moving, making everyday tasks a challenge. Arthrosamid is a modern injectable treatment that has gained popularity for easing knee pain and improving function. This article explores what patients need to know about Arthrosamid injections, including the potential risks, side effects, and overall safety. Drawing on up-to-date research, the goal is to provide clear and practical information so you can feel confident when considering treatment options.

The Safety Profile of Arthrosamid: What Current Evidence Shows

Arthrosamid is a gel-like substance called a polyacrylamide hydrogel, designed to be injected into the knee joint. It acts like a soft scaffolding that supports the joint lining, helping to improve flexibility and reduce inflammation. Unlike some other materials, this hydrogel doesn't break down quickly, so its effects can last a long time. Studies have shown that Arthrosamid can provide lasting pain relief and improve joint function — in some cases for up to five years. Importantly, research confirms its safety: “Injection of PAAG hydrogel intraarticularly into the knee has been shown to be safe with no long-lasting adverse events reported.” Laboratory tests also back this up, showing “2.5 iPAAG had no significant effects on nerve cell survival or health,” which means it does not harm nerve cells in a way that might cause pain or other issues. When given by trained specialists following proper procedures, Arthrosamid has a strong safety record and is a trustworthy non-surgical option for knee osteoarthritis.

Common Side Effects and What to Expect During Recovery

After an Arthrosamid injection, it’s typical to experience some mild side effects around the knee. These might include slight swelling, redness, or tenderness where the injection was given. These symptoms usually clear up within a few days to a couple of weeks. Some people may notice their knee feels a bit stiff or tender for a short while as it adjusts to the new gel inside. These temporary reactions are seen in a minority of patients and generally don’t cause any long-term problems. As noted in studies, “Injection of PAAG hydrogel intraarticularly into the knee has been shown to be safe with no long-lasting adverse events reported.” To help ease any inflammation, your doctor may recommend over-the-counter anti-inflammatory medication for a short period. Your healthcare team will guide you on managing these mild effects and will monitor your recovery closely, ensuring you feel supported every step of the way. It’s also reassuring to know that many patients experience little or no noticeable side effects.

Rare Complications: What You Should Know

Though very rare, more serious complications can happen after Arthrosamid injections. These include allergic reactions or joint infections, but such events are extremely uncommon. A recent review emphasises that “Injection of PAAG hydrogel intraarticularly into the knee has been shown to be safe with no long-lasting adverse events reported.” Compared to other common knee injections like corticosteroids or hyaluronic acid, Arthrosamid carries a similar or sometimes lower risk of severe side effects, thanks to its unique gel formulation. Additionally, research shows “iPAAG outperformed steroid injections at 6 months but did not show superiority over hyaluronic acid,” suggesting a good balance of safety and effectiveness. It’s important to watch for signs such as persistent swelling, worsening pain, fever, or other concerning symptoms — if these occur, seek medical advice promptly. Open communication with your healthcare provider before starting treatment will help you fully understand both the benefits and any possible risks.

Reducing Risk: Best Practices and Expert Support

You can help reduce the chance of side effects by following all aftercare advice from your medical team carefully. This includes taking prescribed medications, avoiding strenuous activity for a short while, and attending all follow-up appointments. Reporting any unusual or ongoing discomfort quickly ensures swift action if needed. The skill and experience of the clinician administering the injection are vital to your safety. Professor Paul Lee, a leading orthopaedic surgeon and cartilage expert, exemplifies the high standards of care patients should seek. Under his guidance, the MSK Doctors team combines expertise with a patient-focused approach to ensure safe, effective treatments. Choosing experienced professionals not only improves your chances of a smooth recovery but also provides peace of mind. For tailored advice, don’t hesitate to consult specialists who understand your individual needs.

Conclusion

Arthrosamid knee injections represent a reliable and generally safe option for managing the symptoms of knee osteoarthritis. Most side effects are mild and short-lived, while serious complications remain very rare. When injections are administered by skilled experts and supported by thorough aftercare, patients can expect a positive balance of benefits and manageable risks. Thanks to advances in treatment and the dedication of clinicians like Professor Paul Lee and teams at MSK Doctors, those living with knee osteoarthritis now have more choices backed by sound clinical evidence. With the right guidance, you can confidently explore these options and take control of your joint health for a more comfortable, active life.

References

• Cole, A., Maulana, R., Whitehead, J., & Lee, P. (2022). A systematic review of the novel compound Arthrosamid polyacrylamide (PAAG) hydrogel for treatment of knee osteoarthritis. Medical Research Archives, 10(8). https://doi.org/10.18103/mra.v10i8.2950
• Aykaç, B., Dinç, M., Nar, Ö. O., Karasu, R., & Bayrak, H. Ç. (2025). Comparative efficacy of polyacrylamide hydrogel versus hyaluronic acid and corticosteroids in knee osteoarthritis: A retrospective cohort study. Medicine, 104(10). https://doi.org/10.1097/MD.0000000000044655
• Walmod, P. S., Kusk, P., Jøhnk, N., Ankorina‐Stark, I., & Essex, A. (2025). An injectable 2.5% cross-linked polyacrylamide hydrogel (2.5 iPAAG) demonstrates no neurotoxicity in human induced pluripotent stem cells-derived iCell® GlutaNeurons. Frontiers in Toxicology. https://doi.org/10.3389/ftox.2025.1585430